169 related articles for article (PubMed ID: 17267544)
1. Calcium/calmodulin-dependent protein kinase II-delta isoform regulation of vascular smooth muscle cell proliferation.
House SJ; Ginnan RG; Armstrong SE; Singer HA
Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2276-87. PubMed ID: 17267544
[TBL] [Abstract][Full Text] [Related]
2. Thymine DNA glycosylase is a key regulator of CaMKIIγ expression and vascular smooth muscle phenotype.
Liu Y; Sun LY; Singer DV; Ginnan R; Zhao W; Jourd'heuil FL; Jourd'heuil D; Long X; Singer HA
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H969-H980. PubMed ID: 31518169
[TBL] [Abstract][Full Text] [Related]
3. CaMKII-delta isoform regulation of neointima formation after vascular injury.
House SJ; Singer HA
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):441-7. PubMed ID: 18096823
[TBL] [Abstract][Full Text] [Related]
4. Ca
Saddouk FZ; Ginnan R; Singer HA
Adv Pharmacol; 2017; 78():171-202. PubMed ID: 28212797
[TBL] [Abstract][Full Text] [Related]
5. Modulation of vascular smooth muscle cell migration by calcium/ calmodulin-dependent protein kinase II-delta 2.
Pfleiderer PJ; Lu KK; Crow MT; Keller RS; Singer HA
Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1238-45. PubMed ID: 14761894
[TBL] [Abstract][Full Text] [Related]
6. PKC-delta and CaMKII-delta 2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle.
Ginnan R; Pfleiderer PJ; Pumiglia K; Singer HA
Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1281-9. PubMed ID: 14749212
[TBL] [Abstract][Full Text] [Related]
7. CaMKIIδ-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscle.
Liu Y; Sun LY; Singer DV; Ginnan R; Singer HA
J Biol Chem; 2013 Nov; 288(47):33519-33529. PubMed ID: 24106266
[TBL] [Abstract][Full Text] [Related]
8. Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling.
Saddouk FZ; Sun LY; Liu YF; Jiang M; Singer DV; Backs J; Van Riper D; Ginnan R; Schwarz JJ; Singer HA
FASEB J; 2016 Mar; 30(3):1051-64. PubMed ID: 26567004
[TBL] [Abstract][Full Text] [Related]
9. iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle.
Jones RJ; Jourd'heuil D; Salerno JC; Smith SM; Singer HA
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2634-42. PubMed ID: 17293490
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIδ (CaMKIIδ).
Liu YF; Spinelli A; Sun LY; Jiang M; Singer DV; Ginnan R; Saddouk FZ; Van Riper D; Singer HA
Sci Rep; 2016 May; 6():26166. PubMed ID: 27199283
[TBL] [Abstract][Full Text] [Related]
11. CaM kinase II delta2-dependent regulation of vascular smooth muscle cell polarization and migration.
Mercure MZ; Ginnan R; Singer HA
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1465-75. PubMed ID: 18385282
[TBL] [Abstract][Full Text] [Related]
12. Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle.
Lu KK; Armstrong SE; Ginnan R; Singer HA
Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1343-50. PubMed ID: 15944210
[TBL] [Abstract][Full Text] [Related]
13. Ca2+/calmodulin-dependent protein kinase II function in vascular remodelling.
Singer HA
J Physiol; 2012 Mar; 590(6):1349-56. PubMed ID: 22124148
[TBL] [Abstract][Full Text] [Related]
14. The multifunctional Ca2+/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21.
Li W; Li H; Sanders PN; Mohler PJ; Backs J; Olson EN; Anderson ME; Grumbach IM
J Biol Chem; 2011 Mar; 286(10):7990-7999. PubMed ID: 21193397
[TBL] [Abstract][Full Text] [Related]
15. Ca
Lin CX; Lv XF; Yuan F; Li XY; Ma MM; Liu CZ; Zhou JG; Wang GL; Guan YY
Circ J; 2018 Feb; 82(3):903-913. PubMed ID: 29081444
[TBL] [Abstract][Full Text] [Related]
16. A role for Ca2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells.
Abraham ST; Benscoter HA; Schworer CM; Singer HA
Circ Res; 1997 Oct; 81(4):575-84. PubMed ID: 9314839
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle cell motility is mediated by a physical and functional interaction of Ca2+/calmodulin-dependent protein kinase IIδ2 and Fyn.
Ginnan R; Zou X; Pfleiderer PJ; Mercure MZ; Barroso M; Singer HA
J Biol Chem; 2013 Oct; 288(41):29703-12. PubMed ID: 24003228
[TBL] [Abstract][Full Text] [Related]
18. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle.
Ginnan R; Singer HA
Am J Physiol Cell Physiol; 2002 Apr; 282(4):C754-61. PubMed ID: 11880263
[TBL] [Abstract][Full Text] [Related]
19. Increased iNOS activity in vascular smooth muscle cells from diabetic rats: potential role of Ca(2+)/calmodulin-dependent protein kinase II delta 2 (CaMKIIδ(2)).
Di Pietro N; Di Tomo P; Di Silvestre S; Giardinelli A; Pipino C; Morabito C; Formoso G; Mariggiò MA; Pandolfi A
Atherosclerosis; 2013 Jan; 226(1):88-94. PubMed ID: 23177014
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.
Li H; Li W; Gupta AK; Mohler PJ; Anderson ME; Grumbach IM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H688-98. PubMed ID: 20023119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
